John M. Maraganore

2015

In 2015, John M. Maraganore earned a total compensation of $8.3M as Chief Executive Officer principal executive officer at Alnylam Pharmaceuticals, a 624% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$419,772
Option Awards$7,123,547
Salary$710,273
Other$7,566
Total$8,261,158

Maraganore received $7.1M in option awards, accounting for 86% of the total pay in 2015.

Maraganore also received $419.8K in non-equity incentive plan, $710.3K in salary and $7.6K in other compensation.

Rankings

In 2015, John M. Maraganore's compensation ranked 742nd out of 13,638 executives tracked by ExecPay. In other words, Maraganore earned more than 94.6% of executives.

ClassificationRankingPercentile
All
742
out of 13,638
95th
Division
Manufacturing
260
out of 5,190
95th
Major group
Chemicals And Allied Products
92
out of 1,854
95th
Industry group
Drugs
72
out of 1,528
95th
Industry
Pharmaceutical Preparations
57
out of 1,182
95th
Source: SEC filing on March 17, 2016.

Maraganore's colleagues

We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2015.

2015

David-Alexandre Gros

Alnylam Pharmaceuticals

Senior Vice President, Chief Business Officer

2015

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2015

Akshay Vaishnaw

Alnylam Pharmaceuticals

Chief Medical Officer

2015

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

News

In-depth

You may also like